High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults
ACHIEVE
AdvanCing High-quality COPD Care for People With Immune Dysfunction by Implementing EVidence-based Management Through Proactive E-consults
1 other identifier
interventional
270
1 country
7
Brief Summary
This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2019
CompletedFirst Posted
Study publicly available on registry
February 27, 2019
CompletedStudy Start
First participant enrolled
May 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedJuly 30, 2025
June 1, 2025
6 years
February 20, 2019
July 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
% of COPD care recommendations received by patients of enrolled providers
% of COPD care recommendations received by the patient, examined collectively for each patient and individually by type of recommendation (e.g. use of spirometry, long acting bronchodilator, smoking cessation, vaccination, etc.) to assess the overall quality of COPD care.
6 months following provider/patient appointment
Secondary Outcomes (1)
Patient health-related quality of life
6 weeks following provider/patient appointment
Other Outcomes (1)
HIV provider satisfaction with specialty-care support
Baseline: prior to intervention roll-out. Follow-up: after exposure to intervention (defined as having received at least 2 E-consults), up to 3 years.
Study Arms (2)
Usual care
NO INTERVENTIONProviders in this arm will provide usual care to their HIV+ patients with COPD.
Proactive E-consult
EXPERIMENTALProviders in this arm will receive proactive E-consults with expert recommendations for COPD care prior to appointments with HIV+ patients with COPD.
Interventions
E-consult recommendations and orders will be developed by a panel of pulmonologists and will address a range of care elements for patients with COPD.
Eligibility Criteria
You may qualify if:
- Providers:
- Outpatient infectious disease providers at one of the seven local sites participating in this study.
- Patients:
- HIV+ patients with COPD treated by providers enrolled in the study.
You may not qualify if:
- Providers:
- Trainees
- Patients:
- Significant cognitive dysfunction, language barriers or severe psychiatric disorder, impairing ability to participate in surveys and interviews.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seattle Institute for Biomedical and Clinical Researchlead
- VA Puget Sound Health Care Systemcollaborator
- Washington D.C. Veterans Affairs Medical Centercollaborator
- VA Eastern Colorado Health Care Systemcollaborator
- University of Colorado, Denvercollaborator
- VA Greater Los Angeles Healthcare Systemcollaborator
- Atlanta VA Medical Centercollaborator
- Yale Universitycollaborator
- VA Connecticut Healthcare Systemcollaborator
- Corporal Michael J. Crescenz VA Medical Centercollaborator
- VA Tennessee Valley Health Care Systemcollaborator
Study Sites (7)
VA Greater Los Angeles Healthcare System
Los Angeles, California, 90073, United States
VA Eastern Colorado Health Care System
Denver, Colorado, 80012, United States
VA Connecticut Healthcare System
New Haven, Connecticut, 06111, United States
Washington DC VA Medical Center
Washington D.C., District of Columbia, 20422, United States
Atlanta VA Health Care System
Atlanta, Georgia, 30033, United States
Philadelphia VA Medical Center
Philadelphia, Pennsylvania, 19104, United States
Nashville VA Medical Center
Nashville, Tennessee, 37212, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David H. Au, MD, MS
VA Puget Sound Health Care System
- PRINCIPAL INVESTIGATOR
Kristina A. Crothers, MD
VA Puget Sound Health Care System
- PRINCIPAL INVESTIGATOR
Christian D. Helfrich, PhD, MPH
VA Puget Sound Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Study staff conducting patient surveys and evaluating quality of COPD care will be blinded to intervention/control assignment of the patient's provider.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2019
First Posted
February 27, 2019
Study Start
May 21, 2019
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
July 30, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share